RAPT Therapeutics

$19.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.00 (-4.93%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RAPT and other stocks, options, and ETFs commission-free!

About RAPT

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases..

CEO
Brian Russell Wong
Employees
68
Headquarters
South San Francisco, California
Founded
2015
Market Cap
522.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
131.45K
High Today
$20.56
Low Today
$19.06
Open Price
$20.37
Volume
79.30K
52 Week High
$41.86
52 Week Low
$13.36

RAPT Earnings

-$12.41
-$8.27
-$4.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

HTPA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure